Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Dec;116(7):2931–2938. doi: 10.1111/j.1476-5381.1995.tb15947.x

Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.

L Negri 1, G Improta 1, R Lattanzi 1, R L Potenza 1, F Luchetti 1, P Melchiorri 1
PMCID: PMC1909203  PMID: 8680727

Abstract

1. In rats, the interaction between the mu-opioid agonist dermorphin and the delta-opioid agonist [D-Ala2, Glu4]deltorphin was studied in binding experiments to delta-opioid receptors and in the antinociceptive test to radiant heat. 2. When injected i.c.v., doses of [D-Ala2, Glu4]deltorphin higher than 20 nmol produced antinociception in the rat tail-flick test to radiant heat. Lower doses were inactive. None of the doses tested elicited the maximum achievable response. This partial antinociception was accomplished with an in vivo occupancy of more than 97% of brain delta-opioid receptors and of 17% of mu-opioid receptors. Naloxone (0.1 mg kg-1, s.c.), and naloxonazine (10 mg kg-1, i.v., 24 h before), but not the selective delta-opioid antagonist naltrindole, antagonized the antinociception. 3. In vitro competitive inhibition studies in rat brain membranes showed that [D-Ala2, Glu4]deltorphin displaced [3H]-naltrindole from two delta-binding sites of high and low affinity. The addition of 100 microM Gpp[NH]p produced a three fold increase in the [D-Ala2, Glu4]deltorphin Ki value for both binding sites. The addition of 10 nM dermorphin increased the Ki value of the delta-agonist for the high affinity site five times. When Gpp[NH]p was added to the incubation medium together with 10 nM dermorphin, the high affinity Ki of the delta-agonist increased 15 times. 4. Co-administration into the rat brain ventricles of subanalgesic doses of dermorphin and [D-Ala2, Glu4]deltorphin resulted in synergistic antinociceptive responses. 5. Pretreatment with naloxone or with the non-equilibrium mu-antagonists naloxonazine and beta-funaltrexamine completely abolished the antinociceptive response of the mu-delta agonist combinations. 6. Pretreatment with the delta-opioid antagonists naltrindole and DALCE reduced the antinociceptive response of the dermorphin-[D-Ala2, Glu4]deltorphin combinations to a value near that observed after the mu-agonist alone. At the dosage used, naltrindole occupied more than 98% of brain delta-opioid receptors without affecting mu-opioid-receptors. 7. These data suggest that in the rat tail-flick test to radiant heat, mu- and delta-opioid agonists co-operate positively in evoking an antinociceptive response. Although interactions between different opioid pathways cannot be excluded, in vitro binding results indicate that this co-operative antinociception is probably mediated by co-activation of the delta-opioid receptors at the cellular level by the mu- and delta-agonist.

Full text

PDF
2931

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. U., Tallarida R. J., Geller E. B., Adler M. W. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J Pharmacol Exp Ther. 1993 Sep;266(3):1261–1267. [PubMed] [Google Scholar]
  2. Calcagnetti D. J., Bowen W. D., Holtzman S. G. Stress-induced tolerance to delta receptor agonist DPDPE and selectivity of the irreversible delta-ligand, DALCE. Brain Res. 1990 Feb 19;509(2):205–212. doi: 10.1016/0006-8993(90)90545-m. [DOI] [PubMed] [Google Scholar]
  3. Calcagnetti D. J., Fleetwood S. W., Holtzman S. G. Pharmacological profile of the potentiation of opioid analgesia by restraint stress. Pharmacol Biochem Behav. 1990 Sep;37(1):193–199. doi: 10.1016/0091-3057(90)90061-l. [DOI] [PubMed] [Google Scholar]
  4. Calcagnetti D. J., Holtzman S. G. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol Biochem Behav. 1991 Jan;38(1):185–190. doi: 10.1016/0091-3057(91)90608-5. [DOI] [PubMed] [Google Scholar]
  5. Dauge V., Petit F., Rossignol P., Roques B. P. Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test). Eur J Pharmacol. 1987 Sep 11;141(2):171–178. doi: 10.1016/0014-2999(87)90260-3. [DOI] [PubMed] [Google Scholar]
  6. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5188–5192. doi: 10.1073/pnas.86.13.5188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heyman J. S., Vaught J. L., Mosberg H. I., Haaseth R. C., Porreca F. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin. Eur J Pharmacol. 1989 Jun 8;165(1):1–10. doi: 10.1016/0014-2999(89)90764-4. [DOI] [PubMed] [Google Scholar]
  8. Holaday J. W., D'Amato R. J. Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shock. Life Sci. 1983;33 (Suppl 1):703–706. doi: 10.1016/0024-3205(83)90599-4. [DOI] [PubMed] [Google Scholar]
  9. Horan P., Tallarida R. J., Haaseth R. C., Matsunaga T. O., Hruby V. J., Porreca F. Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. Life Sci. 1992;50(20):1535–1541. doi: 10.1016/0024-3205(92)90144-e. [DOI] [PubMed] [Google Scholar]
  10. Improta G., Broccardo M. Spinal antinociceptive effects of [D-Ala2]deltorphin II, a novel and highly selective delta-opioid receptor agonist. Peptides. 1992 Nov-Dec;13(6):1123–1126. doi: 10.1016/0196-9781(92)90017-w. [DOI] [PubMed] [Google Scholar]
  11. Jiang Q., Takemori A. E., Sultana M., Portoghese P. S., Bowen W. D., Mosberg H. I., Porreca F. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 1991 Jun;257(3):1069–1075. [PubMed] [Google Scholar]
  12. Kamei J., Iwamoto Y., Suzuki T., Nagase H., Misawa M., Kasuya Y. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice. Eur J Pharmacol. 1993 Mar 30;234(1):117–120. doi: 10.1016/0014-2999(93)90714-s. [DOI] [PubMed] [Google Scholar]
  13. Lee N. M., Leybin L., Chang J. K., Loh H. H. Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur J Pharmacol. 1980 Nov 21;68(2):181–185. doi: 10.1016/0014-2999(80)90319-2. [DOI] [PubMed] [Google Scholar]
  14. Ling G. S., Simantov R., Clark J. A., Pasternak G. W. Naloxonazine actions in vivo. Eur J Pharmacol. 1986 Sep 23;129(1-2):33–38. doi: 10.1016/0014-2999(86)90333-x. [DOI] [PubMed] [Google Scholar]
  15. Mattia A., Vanderah T., Mosberg H. I., Porreca F. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 1991 Aug;258(2):583–587. [PubMed] [Google Scholar]
  16. Melchiorri P., Maritati M., Negri L., Erspamer V. Long-term sensitization to the activation of cerebral delta-opioid receptors by the deltorphin Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 in rats exposed to morphine. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3696–3700. doi: 10.1073/pnas.89.9.3696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Negri L., Lattanzi R., Melchiorri P. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors. Br J Pharmacol. 1995 Jan;114(1):57–66. doi: 10.1111/j.1476-5381.1995.tb14905.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Negri L., Noviello V., Angelucci F. Behavioural effects of deltorphins in rats. Eur J Pharmacol. 1991 Dec 17;209(3):163–168. doi: 10.1016/0014-2999(91)90165-m. [DOI] [PubMed] [Google Scholar]
  19. Porreca F., Heyman J. S., Mosberg H. I., Omnaas J. R., Vaught J. L. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. J Pharmacol Exp Ther. 1987 May;241(2):393–400. [PubMed] [Google Scholar]
  20. Porreca F., Takemori A. E., Sultana M., Portoghese P. S., Bowen W. D., Mosberg H. I. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther. 1992 Oct;263(1):147–152. [PubMed] [Google Scholar]
  21. Qi J. N., Mosberg H. I., Porreca F. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J Pharmacol Exp Ther. 1990 Aug;254(2):683–689. [PubMed] [Google Scholar]
  22. Raffa R. B., Martinez R. P., Porreca F. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse. Eur J Pharmacol. 1992 Jun 17;216(3):453–456. doi: 10.1016/0014-2999(92)90446-b. [DOI] [PubMed] [Google Scholar]
  23. Rossi G. C., Pasternak G. W., Bodnar R. J. Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res. 1994 Nov 28;665(1):85–93. doi: 10.1016/0006-8993(94)91155-x. [DOI] [PubMed] [Google Scholar]
  24. Rothman R. B., Long J. B., Bykov V., Jacobson A. E., Rice K. C., Holaday J. W. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. J Pharmacol Exp Ther. 1988 Nov;247(2):405–416. [PubMed] [Google Scholar]
  25. Rothman R. B., Westfall T. C. Allosteric coupling between morphine and enkephalin receptors in vitro. Mol Pharmacol. 1982 May;21(3):548–557. [PubMed] [Google Scholar]
  26. Rothman R. B., Westfall T. C. Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain. Mol Pharmacol. 1982 May;21(3):538–547. [PubMed] [Google Scholar]
  27. Sheldon R. J., Nunan L., Porreca F. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. J Pharmacol Exp Ther. 1989 May;249(2):462–469. [PubMed] [Google Scholar]
  28. Sofuoglu M., Portoghese P. S., Takemori A. E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther. 1991 May;257(2):676–680. [PubMed] [Google Scholar]
  29. Stamidis H., Young G. A. Mu-delta opioid interactions. I: The delta peptide, DPDPE, increases morphine-induced EEG and EEG spectral power. Peptides. 1992 Jul-Aug;13(4):749–753. doi: 10.1016/0196-9781(92)90182-3. [DOI] [PubMed] [Google Scholar]
  30. Vaught J. L., Takemori A. E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J Pharmacol Exp Ther. 1979 Jan;208(1):86–90. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES